Keynote comment: Cancer drug pricing in the USA.
Johnson
David H
DH
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003363:Cost Control; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics* / Q000941:ethics; D019983:Guideline Adherence; D006801:Humans; D008495:Medical Oncology / Q000191:economics* / Q000639:trends; D010565:Persuasive Communication; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000639:trends; D014481:United States
D000970:Antineoplastic Agents